Who is in your network?

Ready-to-Use Therapeutic Food Market Trends: Fueling Wellness Worldwide

According to FMI’s estimate of the global ready-to-use therapeutics market, the industry’s value is projected to be over US$ 429 million in 2023. FMI projects that by the conclusion of this forecast period, ready-to-use therapeutic food sales would have brought in around US$ 743.4 million in revenue globally.

Due to the fact that malnutrition rates are rising globally, undernutrition accounts for about 45% of deaths in the Under 5 age group. The demand for ready-to-use therapeutic food is developing internationally due to the growing concern of global communities to address the threat through available solutions. 96% of children who got RUTF treatment were shown to be nutritionally well within a year, according to a previous publication in the American Journal of Clinical Nutrition.

To receive a sample copy of the report, go to:
https://www.futuremarketinsigh....ts.com/reports/sampl

It's interesting to note that the Covid-19 pandemic had a significant negative influence on poor and undeveloped nations, although eventually this helped the market. It was discovered that infants who were extremely malnourished had a dangerously high chance of developing the new coronavirus because of their compromised immunity. Therefore, a lot of work was put into providing therapeutic foods that were ready to eat in order to increase their sales on the international market.

Over the course of the projection period, however, it is anticipated that rising costs and a lack of adequate market channels will obstruct the expansion of RTE therapeutic food items. Microbial contamination occurs when producers of RTD medicinal products disregard the WHO's guidelines for food product preparation.

Key Takeaways from the Ready-to-use Therapeutic Food Market Study Report

Based on market survey reports, the sales of ready-to-use therapeutic foods were dominated by the United States, with a revenue share of 23.5% in 2022.
Likewise, Germany is a leading contributor of RTD therapeutic products in the UNICEF programs and held a market share of 14.5% in 2022.
Contrastingly, Asia Pacific countries are performing well these days and have increased their ready-to-eat therapeutic food production capacity to compete globally. While the market for this commodity in China is projected to grow at 4.5% through 2033 India is expected to advance at a 6.5% growth rate.
Competitive Landscape for the Ready-to-use Therapeutic Food Market Players

Nuflower Foods, GC Rieber Compact AS, Valid Nutrition, InnoFaso Corp., Edesia Inc., Nutrivita Foods Ltd., Diva Nutritional Products, Insta Products Ltd., Mana Nutritive Aid Product Inc., Meds & Food for Kids Inc., Samil Industrial Co., Tabatchnick Fine Foods Inc., Amul India Inc., Hilina Enriched Foods PLC, and Société de Transformation Alimentaire among others are some key players in the global ready-to-use therapeutic food market.

Throughout the forecast period, the overall market is expected to remain consolidated due to the presence of a few key players globally. Market growth is anticipated to accelerate due to an increase in collaborations in the regional markets for the production of RUTF at a higher quantity.

For example, the Federal Government of Nigeria signed an MOU with UNICEF in May 2018 to acquire and supply RUTF in the country in huge quantities. The cooperation aimed to act as a parallel contribution to the acquisition and delivery of the goods throughout the state’s six affected zones.

For More Information Click Here:
https://www.futuremarketinsigh....ts.com/reports/ready

Industry Key Segment

By Type:

Solid Therapeutic Food
Power or Blend Form
Biscuits or Bar Form
Paste Therapeutic Food
Drinkable Therapeutic Food
Other Ready-to-use Therapeutic Foods